Cargando…
SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens
Correspondence between the T-cell epitope responses of vaccine immunogens and those of pathogen antigens is critical to vaccine efficacy. In the present study, we analyzed the spectrum of immune responses of mice to three different forms of the SARS coronavirus nucleocapsid (N): (1) exogenous recomb...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111852/ https://www.ncbi.nlm.nih.gov/pubmed/16387339 http://dx.doi.org/10.1016/j.virol.2005.11.042 |
_version_ | 1783513371218280448 |
---|---|
author | Gupta, Vandana Tabiin, Tani M. Sun, Kai Chandrasekaran, Ananth Anwar, Azlinda Yang, Kun Chikhlikar, Priya Salmon, Jerome Brusic, Vladimir Marques, Ernesto T.A. Kellathur, Srinivasan N. August, Thomas J. |
author_facet | Gupta, Vandana Tabiin, Tani M. Sun, Kai Chandrasekaran, Ananth Anwar, Azlinda Yang, Kun Chikhlikar, Priya Salmon, Jerome Brusic, Vladimir Marques, Ernesto T.A. Kellathur, Srinivasan N. August, Thomas J. |
author_sort | Gupta, Vandana |
collection | PubMed |
description | Correspondence between the T-cell epitope responses of vaccine immunogens and those of pathogen antigens is critical to vaccine efficacy. In the present study, we analyzed the spectrum of immune responses of mice to three different forms of the SARS coronavirus nucleocapsid (N): (1) exogenous recombinant protein (N-GST) with Freund's adjuvant; (2) DNA encoding unmodified N as an endogenous cytoplasmic protein (pN); and (3) DNA encoding N as a LAMP-1 chimera targeted to the lysosomal MHC II compartment (p-LAMP-N). Lysosomal trafficking of the LAMP/N chimera in transfected cells was documented by both confocal and immunoelectron microscopy. The responses of the immunized mice differed markedly. The strongest T-cell IFN-γ and CTL responses were to the LAMP-N chimera followed by the pN immunogen. In contrast, N-GST elicited strong T cell IL-4 but minimal IFN-γ responses and a much greater antibody response. Despite these differences, however, the immunodominant T-cell ELISpot responses to each of the three immunogens were elicited by the same N peptides, with the greatest responses being generated by a cluster of five overlapping peptides, N(76–114), each of which contained nonameric H2(d) binding domains with high binding scores for both class I and, except for N(76–93), class II alleles. These results demonstrate that processing and presentation of N, whether exogenously or endogenously derived, resulted in common immunodominant epitopes, supporting the usefulness of modified antigen delivery and trafficking forms and, in particular, LAMP chimeras as vaccine candidates. Nevertheless, the profiles of T-cell responses were distinctly different. The pronounced Th-2 and humoral response to N protein plus adjuvant are in contrast to the balanced IFN-γ and IL-4 responses and strong memory CTL responses to the LAMP-N chimera. |
format | Online Article Text |
id | pubmed-7111852 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71118522020-04-02 SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens Gupta, Vandana Tabiin, Tani M. Sun, Kai Chandrasekaran, Ananth Anwar, Azlinda Yang, Kun Chikhlikar, Priya Salmon, Jerome Brusic, Vladimir Marques, Ernesto T.A. Kellathur, Srinivasan N. August, Thomas J. Virology Article Correspondence between the T-cell epitope responses of vaccine immunogens and those of pathogen antigens is critical to vaccine efficacy. In the present study, we analyzed the spectrum of immune responses of mice to three different forms of the SARS coronavirus nucleocapsid (N): (1) exogenous recombinant protein (N-GST) with Freund's adjuvant; (2) DNA encoding unmodified N as an endogenous cytoplasmic protein (pN); and (3) DNA encoding N as a LAMP-1 chimera targeted to the lysosomal MHC II compartment (p-LAMP-N). Lysosomal trafficking of the LAMP/N chimera in transfected cells was documented by both confocal and immunoelectron microscopy. The responses of the immunized mice differed markedly. The strongest T-cell IFN-γ and CTL responses were to the LAMP-N chimera followed by the pN immunogen. In contrast, N-GST elicited strong T cell IL-4 but minimal IFN-γ responses and a much greater antibody response. Despite these differences, however, the immunodominant T-cell ELISpot responses to each of the three immunogens were elicited by the same N peptides, with the greatest responses being generated by a cluster of five overlapping peptides, N(76–114), each of which contained nonameric H2(d) binding domains with high binding scores for both class I and, except for N(76–93), class II alleles. These results demonstrate that processing and presentation of N, whether exogenously or endogenously derived, resulted in common immunodominant epitopes, supporting the usefulness of modified antigen delivery and trafficking forms and, in particular, LAMP chimeras as vaccine candidates. Nevertheless, the profiles of T-cell responses were distinctly different. The pronounced Th-2 and humoral response to N protein plus adjuvant are in contrast to the balanced IFN-γ and IL-4 responses and strong memory CTL responses to the LAMP-N chimera. Elsevier Inc. 2006-03-30 2006-01-04 /pmc/articles/PMC7111852/ /pubmed/16387339 http://dx.doi.org/10.1016/j.virol.2005.11.042 Text en Copyright © 2005 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Gupta, Vandana Tabiin, Tani M. Sun, Kai Chandrasekaran, Ananth Anwar, Azlinda Yang, Kun Chikhlikar, Priya Salmon, Jerome Brusic, Vladimir Marques, Ernesto T.A. Kellathur, Srinivasan N. August, Thomas J. SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens |
title | SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens |
title_full | SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens |
title_fullStr | SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens |
title_full_unstemmed | SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens |
title_short | SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens |
title_sort | sars coronavirus nucleocapsid immunodominant t-cell epitope cluster is common to both exogenous recombinant and endogenous dna-encoded immunogens |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111852/ https://www.ncbi.nlm.nih.gov/pubmed/16387339 http://dx.doi.org/10.1016/j.virol.2005.11.042 |
work_keys_str_mv | AT guptavandana sarscoronavirusnucleocapsidimmunodominanttcellepitopeclusteriscommontobothexogenousrecombinantandendogenousdnaencodedimmunogens AT tabiintanim sarscoronavirusnucleocapsidimmunodominanttcellepitopeclusteriscommontobothexogenousrecombinantandendogenousdnaencodedimmunogens AT sunkai sarscoronavirusnucleocapsidimmunodominanttcellepitopeclusteriscommontobothexogenousrecombinantandendogenousdnaencodedimmunogens AT chandrasekaranananth sarscoronavirusnucleocapsidimmunodominanttcellepitopeclusteriscommontobothexogenousrecombinantandendogenousdnaencodedimmunogens AT anwarazlinda sarscoronavirusnucleocapsidimmunodominanttcellepitopeclusteriscommontobothexogenousrecombinantandendogenousdnaencodedimmunogens AT yangkun sarscoronavirusnucleocapsidimmunodominanttcellepitopeclusteriscommontobothexogenousrecombinantandendogenousdnaencodedimmunogens AT chikhlikarpriya sarscoronavirusnucleocapsidimmunodominanttcellepitopeclusteriscommontobothexogenousrecombinantandendogenousdnaencodedimmunogens AT salmonjerome sarscoronavirusnucleocapsidimmunodominanttcellepitopeclusteriscommontobothexogenousrecombinantandendogenousdnaencodedimmunogens AT brusicvladimir sarscoronavirusnucleocapsidimmunodominanttcellepitopeclusteriscommontobothexogenousrecombinantandendogenousdnaencodedimmunogens AT marquesernestota sarscoronavirusnucleocapsidimmunodominanttcellepitopeclusteriscommontobothexogenousrecombinantandendogenousdnaencodedimmunogens AT kellathursrinivasann sarscoronavirusnucleocapsidimmunodominanttcellepitopeclusteriscommontobothexogenousrecombinantandendogenousdnaencodedimmunogens AT augustthomasj sarscoronavirusnucleocapsidimmunodominanttcellepitopeclusteriscommontobothexogenousrecombinantandendogenousdnaencodedimmunogens |